Different Beats of Dia“Beat”es
Abstract
No abstract
References
1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53.
2. Rhee EJ. Diabetes in Asians. EndocrinolMetab (Seoul). 2015 Sep;30(3):263-9. doi: 10.3803/EnM.2015.30.3.263.
3. Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005
Sep;53:759-63.
4. Tyagi R, Patel S, Waran M. Evaluation Of Risk For Type 2 Diabetes Mellitus In 1st Degree Relatives Using Indian Diabetes Risk Score (Idrs). The Indian Practitioner. 2015;68(11):32-34.
5. Schernthaner G. Diabetes and Cardiovascular Disease: Is intensive glucosecontrol beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS,PROactive, and NICE-SUGAR. Wien Med Wochenschr. 2010 Jan;160(1-2):8- 19.
6. Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev. 2015 Oct 9. doi:10.1002/dmrr.2738. [Epub ahead of print] PubMed PMID: 26452160.
7. Kavitha KV, Unnikrishnan AG. Managing diabetic foot problems- a clinical perspective. The Indian Practitioner. 2015;68(10): The Indian Practitioner. 2015;68(11):62-69.
8. Yamamoto C, Miyoshi H, Fujiwara Y, Kameda R, Ichiyama M, Nomoto H, Kameda H,Nakamura A, Atsumi T. Degludec is superior to glargine in terms of daily glycemic variability
in people with type 1 diabetes mellitus. Endocr J. 2015 Oct 31. [Epub ahead of print] PubMed PMID: 26522272.
9. Kalra S, Joshi A, Parmar G. Insulin therapy: going the “smarter” way. Recent Pat EndocrMetab Immune Drug Discov. 2014;8(2):79-84.
10. Espinoza-Peralta D, Rogel-Manzanares J. Newer and Future Insulins. The Indian Practitioner. 2015;68(11):56-61.
11. Consensus Development Conference Panel. Gastrointestinal Surgery for Severe Obesity. Ann Intern Med 1991;115(12):956- 61
12. Kota S K, Naik DB, ModiKd, Dalwadi P. Bariatric Surgery for Type 2 Diabetes: Armour in making.The Indian Practitioner. 2015;68(11):37-45.
13. Virani ZA, Jain S, Badhe R, Udare A. Emphysematous pyelonephritis in Diabetes: A case report. The Indian Practitioner. 2015;68(11):46-49.
2. Rhee EJ. Diabetes in Asians. EndocrinolMetab (Seoul). 2015 Sep;30(3):263-9. doi: 10.3803/EnM.2015.30.3.263.
3. Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005
Sep;53:759-63.
4. Tyagi R, Patel S, Waran M. Evaluation Of Risk For Type 2 Diabetes Mellitus In 1st Degree Relatives Using Indian Diabetes Risk Score (Idrs). The Indian Practitioner. 2015;68(11):32-34.
5. Schernthaner G. Diabetes and Cardiovascular Disease: Is intensive glucosecontrol beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS,PROactive, and NICE-SUGAR. Wien Med Wochenschr. 2010 Jan;160(1-2):8- 19.
6. Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev. 2015 Oct 9. doi:10.1002/dmrr.2738. [Epub ahead of print] PubMed PMID: 26452160.
7. Kavitha KV, Unnikrishnan AG. Managing diabetic foot problems- a clinical perspective. The Indian Practitioner. 2015;68(10): The Indian Practitioner. 2015;68(11):62-69.
8. Yamamoto C, Miyoshi H, Fujiwara Y, Kameda R, Ichiyama M, Nomoto H, Kameda H,Nakamura A, Atsumi T. Degludec is superior to glargine in terms of daily glycemic variability
in people with type 1 diabetes mellitus. Endocr J. 2015 Oct 31. [Epub ahead of print] PubMed PMID: 26522272.
9. Kalra S, Joshi A, Parmar G. Insulin therapy: going the “smarter” way. Recent Pat EndocrMetab Immune Drug Discov. 2014;8(2):79-84.
10. Espinoza-Peralta D, Rogel-Manzanares J. Newer and Future Insulins. The Indian Practitioner. 2015;68(11):56-61.
11. Consensus Development Conference Panel. Gastrointestinal Surgery for Severe Obesity. Ann Intern Med 1991;115(12):956- 61
12. Kota S K, Naik DB, ModiKd, Dalwadi P. Bariatric Surgery for Type 2 Diabetes: Armour in making.The Indian Practitioner. 2015;68(11):37-45.
13. Virani ZA, Jain S, Badhe R, Udare A. Emphysematous pyelonephritis in Diabetes: A case report. The Indian Practitioner. 2015;68(11):46-49.
Published
2019-08-06
How to Cite
Dr. (Prof.) Premlata Varthakavi, Joshi A,. (2019). Different Beats of Dia“Beat”es. The Indian Practitioner, 68(11), 7-8. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/527
Section
Editorial
